Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	1620401-82-2
Formula :	C₂₃H₃₅N₅O₂
M.W :	413.56
SMILES Code :	COC1=CC2=NC(N3CCCC3)=NC(NCCCCCN4CCCC4)=C2C=C1OC
MDL No. :	MFCD28167817
InChI Key :	WEXCGGWTIDNVNT-UHFFFAOYSA-N
Pubchem ID :	78357767

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

Mouse 5T33MMvv cells	2.5 µM to 40 µM	24 hours	Evaluate the toxic effects of UNC-0379 on murine MM cell models, showing a significant reduction in cell viability.	Clin Epigenetics. 2021 Sep 16;13(1):174.
Primary MM cells	1 µM, 2.5 µM, 5 µM	4 days	Assess the toxic effects of UNC-0379 on primary MM cells, demonstrating a significant reduction in malignant plasma cell numbers.	Clin Epigenetics. 2021 Sep 16;13(1):174.
Human myeloma cell lines (HMCLs)	1 µM, 2.5 µM, 5 µM	4 days	Evaluate the toxic effects of UNC-0379 on HMCLs, showing dose-dependent inhibition of cell growth.	Clin Epigenetics. 2021 Sep 16;13(1):174.
NHLF	10 µM	48 hours	UNC0379 was sensitive to the upregulation of ED-A-FN in NHLF, suggesting that SET8 may be involved in TGF-β1-induced FMD in normal fibroblasts.	Front Mol Biosci. 2020 Aug 5;7:192.
IPF-MyoF	10 µM	48 hours	UNC0379 significantly suppressed the expression of α-SMA and ED-A-FN, reversing the phenotype of IPF-MyoF.	Front Mol Biosci. 2020 Aug 5;7:192.
TYK-nu	10 µM	72 hours	Inhibition of cell proliferation and induction of apoptosis	Biomolecules. 2020 Dec 16;10(12):1686.
OVCAR3	10 µM	96 hours	Inhibition of cell proliferation and induction of apoptosis	Biomolecules. 2020 Dec 16;10(12):1686.
JHOS3	10 µM	96 hours	Inhibition of cell proliferation and induction of apoptosis	Biomolecules. 2020 Dec 16;10(12):1686.
MDA-MB-231 cells	5 or 10 µM	48 hours	To verify the inhibitory effect of UNC0379 on the proliferation of breast cancer cells, the results showed that as the concentration of UNC0379 increased, the proliferation of MDA-MB-231 cells was more strongly inhibited.	Oncol Rep. 2024 Aug;52(2):110.
CR-CSphCs	0.5, 1, 2, 4, 8 µg/ml	48 hours	Evaluating the effect of UNC0379 on CR-CSphCs, results showed that UNC0379 treatment led to a gradual decrease in p53K382me1 and H4K20me1 protein levels while restoring p53 and p21 levels and reducing colony-forming capability.	Mol Cancer. 2025 Mar 31;24(1):102.
THP1 cells	0.5, 1, 2, 4, 8 µg/ml	48 hours	Evaluating the effect of UNC0379 on THP1 cells, results showed that UNC0379 treatment led to a gradual decrease in p53K382me1 and H4K20me1 protein levels while restoring p53 and p21 levels.	Mol Cancer. 2025 Mar 31;24(1):102.
BMSC cells	2 µM	48 hours	Evaluate the cytotoxicity of UNC0379 on BMSC cells, results showed BMSC cells were not sensitive to UNC0379.	Cell Death Dis. 2024 Jul 10;15(7):494.
SK-NEP-1 cells	2 µM	48 hours	Evaluate the cytotoxicity of UNC0379 on SK-NEP-1 cells, results showed SK-NEP-1 cells were sensitive to UNC0379.	Cell Death Dis. 2024 Jul 10;15(7):494.
SKNMC cells	2 µM	48 hours	Evaluate the cytotoxicity of UNC0379 on SKNMC cells, results showed SKNMC cells were sensitive to UNC0379.	Cell Death Dis. 2024 Jul 10;15(7):494.
Glioblastoma primary cells	5 µM	48 hours	SETD8 inhibition resulted in p53 protein stabilization and p21 accumulation	Cell Death Dis. 2023 Sep 27;14(9):638.
SW1088 cells	5 µM	48 hours	SETD8 inhibition resulted in increased DNA damage, Chk1 phosphorylation, and G2/M arrest	Cell Death Dis. 2023 Sep 27;14(9):638.
U251 cells	5 µM	48 hours	SETD8 inhibition resulted in increased DNA damage, Chk1 phosphorylation, and G2/M arrest	Cell Death Dis. 2023 Sep 27;14(9):638.
LN-18 cells	5 µM	48 hours	SETD8 inhibition resulted in increased DNA damage, p53 protein stabilization, p21 accumulation, and G1/S arrest	Cell Death Dis. 2023 Sep 27;14(9):638.
U87MG cells	5 µM	48 hours	SETD8 inhibition resulted in increased DNA damage, p53 protein stabilization, p21 accumulation, and G1/S arrest	Cell Death Dis. 2023 Sep 27;14(9):638.
CaSki cells	9.97 ± 0.58 µM (IC50)	48 hours	UNC0379 enhanced the sensitivity of CaSki cells to cisplatin, reducing the IC50 value.	Cell Biosci. 2023 Jun 12;13(1):107.
SiHa cells	8.73 ± 0.49 µM (IC50)	48 hours	UNC0379 enhanced the sensitivity of SiHa cells to cisplatin, reducing the IC50 value.	Cell Biosci. 2023 Jun 12;13(1):107.
SK-N-BE2C (MYCN-amp)	0.1-30 µM	7 days	UNC0379 exhibited antitumor activity in MYCN-amplified NB cell lines with IC50 values ranging from 0.64 to 7 μM.	Cancer Cell. 2017 Jan 9;31(1):50-63.
SY5Y (MYCN-WT)	0.1-30 µM	7 days	UNC0379, a selective, substrate-competitive inhibitor of SETD8, was one of the most active compounds, exhibiting a relatively low average IC50 (2 μM) and a highly significant p value for the In Vitro Therapeutic Index (IVTI) across the 8 NB cell lines compared with control cell lines.	Cancer Cell. 2017 Jan 9;31(1):50-63.
Huh-7 cells	5 µM and 10 µM	72 hours	UNC0379 significantly inhibited the proliferation, migration, and invasion of Huh-7 cells.	Sci Rep. 2020 Mar 11;10(1):4490.
SMMC-7721 cells	5 µM and 10 µM	72 hours	UNC0379 significantly inhibited the proliferation, migration, and invasion of SMMC-7721 cells.	Sci Rep. 2020 Mar 11;10(1):4490.
RDES cells	2 µM	72 hours	Evaluate the cytotoxicity of UNC0379 on RDES cells, results showed RDES cells were sensitive to UNC0379.	Cell Death Dis. 2024 Jul 10;15(7):494.
A673 cells	2 µM	72 hours	Evaluate the cytotoxicity of UNC0379 on A673 cells, results showed A673 cells were sensitive to UNC0379.	Cell Death Dis. 2024 Jul 10;15(7):494.

C57BL/6J mice	BLM-induced lung fibrosis model	Intratracheal administration	1 mg/kg/day	Administered at 7, 8, and 9 dpi	UNC0379 significantly ameliorated BLM-induced lung fibrosis without affecting inflammatory responses.	Front Mol Biosci. 2020 Aug 5;7:192.
Nude mice	Neuroblastoma xenograft model	Ex-vivo treatment followed by subcutaneous implantation	2 μM	Single treatment for 24 hours followed by implantation and tumor growth monitoring	UNC0379 treatment significantly inhibited tumor growth of SY5Y and NGP neuroblastoma cells in vivo and significantly prolonged murine survival.	Cancer Cell. 2017 Jan 9;31(1):50-63.
Nude mice	A673 cell xenograft model		30 mg/kg/day	Once daily for 14 days	Evaluate the anti-tumor effect of UNC0379 in vivo, results showed UNC0379 significantly reduced tumor volume and weight.	Cell Death Dis. 2024 Jul 10;15(7):494.
NSG mice	Subcutaneous and intrasplenic injection models	Intraperitoneal injection	5 mg/kg	3 times per week for 3 weeks	Evaluating the effect of UNC0379 on tumor growth and metastasis in vivo, results showed that UNC0379 alone or in combination with Tocilizumab delayed disease progression and prolonged survival.	Mol Cancer. 2025 Mar 31;24(1):102.
C57BL/6J mice	Cisplatin-induced acute kidney injury (AKI) model	Intraperitoneal injection	5 mg/kg	Once daily for three consecutive days	To investigate the effect of UNC0379 on cisplatin-induced AKI, results showed that UNC0379 improved renal function, attenuated renal tubular damage, and restored PTEN expression.	Cell Death Dis. 2025 Mar 31;16(1):226.
BALB/c nude mice	Subcutaneous tumor model	Intraperitoneal and subcutaneous injection	5 mg/kg	Twice weekly cisplatin and thrice weekly UNC0379 for 18 days	UNC0379 significantly reduced tumor size and weight, enhancing the therapeutic effect of cisplatin.	Cell Biosci. 2023 Jun 12;13(1):107.
CD1 mice	Glioblastoma xenograft model		5 μM UNC0379 + 400 nM adavosertib	From day 8 to day 21	UNC0379 and adavosertib combination significantly inhibited glioblastoma growth	Cell Death Dis. 2023 Sep 27;14(9):638.

{[proInfo.proName]}

CAS No.: 1620401-82-2

{[proInfo.proName]}

CAS No.: 1620401-82-2

Alternative Products

Product Details of UNC0379

Safety of UNC0379

Related Pathways of UNC0379

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	2.42mL 0.48mL 0.24mL	12.09mL 2.42mL 1.21mL	24.18mL 4.84mL 2.42mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed